Kevin Yeaman Sells 26,766 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 26,766 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $66.74, for a total transaction of $1,786,362.84. Following the transaction, the chief executive officer owned 105,128 shares of the company’s stock, valued at $7,016,242.72. This trade represents a 20.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Dolby Laboratories Price Performance

DLB traded up $0.29 during midday trading on Wednesday, reaching $67.09. 575,384 shares of the company’s stock were exchanged, compared to its average volume of 610,696. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The stock has a market capitalization of $6.41 billion, a PE ratio of 25.51 and a beta of 0.89. The business’s 50-day moving average price is $66.88 and its 200 day moving average price is $71.25.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. During the same period last year, the company posted $0.61 EPS. The company’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, analysts expect that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.1%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, December 2nd. Dolby Laboratories’s payout ratio is presently 54.75%.

Wall Street Analyst Weigh In

A number of research firms recently commented on DLB. Baird R W raised Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Rosenblatt Securities reduced their target price on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Barrington Research lowered their price target on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors and hedge funds have recently bought and sold shares of DLB. Boothbay Fund Management LLC boosted its position in Dolby Laboratories by 4.1% during the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares during the period. MAI Capital Management lifted its stake in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares in the last quarter. Mitchell & Pahl Private Wealth LLC boosted its position in shares of Dolby Laboratories by 1.1% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock worth $1,139,000 after buying an additional 170 shares during the period. Equitable Trust Co. grew its stake in shares of Dolby Laboratories by 3.3% in the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock valued at $413,000 after buying an additional 177 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC grew its stake in shares of Dolby Laboratories by 13.9% in the second quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock valued at $118,000 after buying an additional 194 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.